CPC C07D 249/12 (2013.01) [A61P 3/10 (2018.01); A61P 9/04 (2018.01); A61P 9/10 (2018.01); A61P 9/12 (2018.01); A61P 13/12 (2018.01); C07D 401/04 (2013.01); C07D 403/06 (2013.01); C07D 403/12 (2013.01); C07D 405/04 (2013.01); C07D 405/14 (2013.01); C07D 409/04 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 487/04 (2013.01); G16B 25/00 (2019.02); G16C 20/50 (2019.02); G16C 99/00 (2019.02)] | 20 Claims |
1. A pharmaceutical composition comprising a compound represented by formula (I), or a pharmacologically acceptable salt thereof:
wherein
X1 is —N═ or —CH═,
X2 is —CH═ or —N═,
R1 and R2 are each independently a C1 to C6 alkyl group, a C1 to C6 alkoxy group, or a halogeno group, wherein the C1 to C6 alkyl group and the C1 to C6 alkoxy group are each optionally substituted by 1 to 3 fluoro groups;
R3 is a furyl group, a thienyl group, a pyridyl group, a phenyl group, a n-butyl group, or a cyclopentyl group (the furyl group, the thienyl group, the pyridyl group, and the phenyl group are each optionally substituted by 1 or 2 identical or different groups selected from a methyl group and a halogeno group); and
R4 is
an active ingredient.
|